Medical devices; warning statements for devices containing or manufactured with chlorofluorocarbons and other class I ozone-depleting substances. Medical devices; expiration of exemptions. (e) If a product fails the physical and mechanical integrity tests commonly used by industry after the completion of the accelerated storage tests described in paragraphs (d)(1) and (d)(2) of this section, the product expiration date must be demonstrated by real time storage conditions described in paragraph (d)(3) of this section. (c) If the information specified in paragraph (d) of this section is to be included as a package insert, the following alert statement shall appear prominently and legibly on the package label: Attention: Tampons are associated with Toxic Shock Syndrome (TSS). (1) For prescription and restricted device products, the following alternative warning statement may be used: The indented statement below is required by the Federal government's Clean Air Act for all products containing or manufactured with chlorofluorocarbons (CFC's) [or name of other class I substance, if applicable]: This product contains [or is manufactured with, if applicable] [insert name of substance], a substance which harms the environment by destroying ozone in the upper atmosphere. (e) The declaration shall appear as a distinct item on the principal display panel, shall be separated, by at least a space equal to the height of the lettering used in the declaration, from other printed label information appearing above or below the declaration and, by at least a space equal to twice the width of the letter N of the style of type used in the quantity of contents statement, from other printed label information appearing to the left or right of the declaration. 6 oz or 6 oz net wt., and 6 fl oz or net contents 6 fl oz.. 801.125 Medical devices for use in teaching, law enforcement, research, and analysis. (a) Examination of data available on the frequency of eye injuries resulting from the shattering of ordinary crown glass lenses indicates that the use of such lenses constitutes an avoidable hazard to the eye of the wearer. (f) In addition, those persons conducting tests in accordance with paragraph (d) of this section shall maintain the results thereof and a description of the test method and of the test apparatus for a period of 3 years. 201.56 Requirements on content and format of labeling for human prescription drug and biological products. A device shall be exempt from section 502(f)(1) of the act insofar as adequate directions for common uses thereof are known to the ordinary individual. This web site is designed for the current versions of Basics of FDA Food Labeling Requirements FDA Reader 801.437 User labeling for devices that contain natural rubber. (ii) The following cautions and notices for users, which shall appear prior to any content, except the cover page and the warnings under paragraph (c)(2)(i) of this section: (B) Caution about excessive sound output. Exceptions or alternatives to labeling requirements for medical devices held by the Strategic National Stockpile. Exemptions From Adequate Directions for Use. (6) Misbranding. Medical device 'labeling' as the term is , as defined by the Food Drug and Cosmetic Act (FDCA), exceeds just the printed label on the device and . 801.63 Medical devices; warning statements for devices containing or manufactured with chlorofluorocarbons and other class I ozone-depleting substances. (3) The FDA labeler code that the labeler wants to continue using. Subpart BLabeling Requirements for Unique Device Identification. 801.116 Medical devices having commonly known directions. (2) A production identifiera conditional, variable portion of a UDI that identifies one or more of the following when included on the label of the device: (i) The lot or batch within which a device was manufactured; (ii) The serial number of a specific device; (iii) The expiration date of a specific device; (iv) The date a specific device was manufactured; (v) For an HCT/P regulated as a device, the distinct identification code required by 1271.290(c) of this chapter. This section does not apply to group auditory trainers. (a) The appropriate FDA Center Director may grant an exception or alternative to any provision listed in paragraph (f) of this section and not explicitly required by statute, for specified lots, batches, or other units of a medical device, if the Center Director determines that compliance with such labeling requirement could adversely affect the safety, effectiveness, or availability of such devices that are or will be included in the Strategic National Stockpile. 801.127 Medical devices; expiration of exemptions. Long term use may lead to more troubles, even permanent changes in bones, teeth, and gums, which may make it impossible to wear dentures in the future. (ii) The Center Director may grant an exception or alternative described in paragraph (a) of this section on his or her own initiative. (vii) Identification of any known physiological side effects associated with the use of the prescription hearing aid that may warrant consultation with a physician, referring to an ear-nose-throat doctor when preferable, including if applicable, skin irritation and accelerated accumulation of cerumen (ear wax). (3) If the labeling contains any representation in a foreign language, all words, statements, and other information required by or under authority of the act to appear on the label or labeling shall appear on the labeling in the foreign language. Sale includes a lease, rental, or any other purchase or exchange for value. will also bring you to search results. Label has the meaning set forth in section 201(k) of the Federal Food, Drug, and Cosmetic Act. The absorbency of the tampon is determined by subtracting its dry weight from this value. It is sufficient to distinguish avoirdupois ounce from fluid ounce through association of terms; for example, Net wt. Choosing an item from (c) This section does not replace or relieve a person from any requirements imposed under 40 CFR part 82. The official, published CFR, is updated annually and available below under The diameter or contour of the lens support may be modified as necessary so that the 18- by 18-inch neoprene gasket supports the lens at its periphery. (a) Scope. For example, January 2, 2014, must be presented as 20140102. Any additional warnings the manufacturer may include prior to the cautions and notices to users in paragraph (c)(2)(ii) of this section. Pharmaceutical Labeling: Requirements & Guidelines You may inspect a copy at the FDA Main Library, 10903 New Hampshire Ave., Bldg. 4, 2016; 85 FR 18441, Apr. The Federal Food, Drug and Cosmetic Act (FFDCA) is the law under which the FDA takes action against regulated products. In the case of cylindrical or nearly cylindrical containers, information required by this part to appear on the principal display panel shall appear within that 40 percent of the circumference which is most likely to be displayed, presented, shown, or examined under customary conditions of display for retail sale. FDALabel - U.S. Food and Drug Administration If you have comments or suggestions on how to improve the www.ecfr.gov website or have questions about using www.ecfr.gov, please choose the 'Website Feedback' button below. (The test result shall be discarded if fluid is detected in the folds of the condom before the tampon is saturated). (c) The declaration may contain common or decimal fractions. (iii) Average saturation output (High Frequency (HF)-Average SSPL 90). (2) accompanying such article' at any time while a device is held for sale after shipment or delivery for shipment in interstate commerce. (ii) Provides instructions for maintaining proper records or otherwise accounting for the number of units in each shipment to insure that the number of units shipped is the same as the number received and sterilized. (d) Except as provided under paragraph (f) of this section, the expiration date must be supported by data demonstrating physical and mechanical integrity of the product after three discrete and representative lots of the product have been subjected to each of the following conditions: (1) Storage of unpackaged bulk product for the maximum amount of time the manufacturer allows the product to remain unpackaged, followed by storage of the packaged product at 70 C (plus or minus 2 C) for 7 days; (2) Storage of unpackaged bulk product for the maximum amount of time the manufacturer allows the product to remain unpackaged, followed by storage of the packaged product at a selected temperature between 40 and 50 C (plus or minus 2 C) for 90 days; and. (i) Any affected person may request an exemption or variance from the requirements of this section by submitting a citizen petition in accordance with 10.30 of this chapter. [1]The Director of the Federal Register approves this incorporation by reference in accordance with 5 U.S.C. If you have questions for the Agency that issued the current document please contact the agency directly. (1) All prescription and restricted device products containing or manufactured with chlorofluorocarbons, halons, carbon tetrachloride, methyl chloride, or any other class I substance designated by the Environmental Protection Agency (EPA) shall, except as provided in paragraph (b) of this section, bear the following warning statement: (2) The warning statement shall be clearly legible and conspicuous on the product, its immediate container, its outer packaging, or other labeling in accordance with the requirements of 40 CFR part 82 and appear with such prominence and conspicuousness as to render it likely to be read and understood by consumers under normal conditions of purchase. The indented statement below is required by the Federal government's Clean Air Act for all products containing or manufactured with chlorofluorocarbons (CFC's) [or other class I substance, if applicable]: CONSULT WITH YOUR PHYSICIAN, HEALTH PROFESSIONAL, OR SUPPLIER IF YOU HAVE ANY QUESTION ABOUT THE USE OF THIS PRODUCT. 801.55 Request for an exception from or alternative to a unique device identifier requirement. ANSI/ASA S3.222014 (R2020), AMERICAN NATIONAL STANDARD Specification of Hearing Aid Characteristics, dated June 5, 2020, is incorporated by reference into this section with the approval of the Director of the Office of the Federal Register under 5 U.S.C. (2) If the label contains any representation in a foreign language, all words, statements, and other information required by or under authority of the act to appear on the label shall appear thereon in the foreign language. 19, 2018, at, Food and Drug Administration, Department of Health and Human Services, https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-801. This can be expressed in terms of weight, measure, count or a combination. [62 FR 51029, Sept. 30, 1997, as amended at 63 FR 46175, Aug. 31, 1998]. Compliance FAQs: Packaging and Labeling in the US | NIST (1) A declaration of 112 pounds weight shall be expressed as net wt. A lens manufacturer shall conduct tests of lenses using the impact test described in paragraph (d)(2) of this section or any equal or superior test. 801.50 Labeling requirements for stand-alone software. Drugs marked "OTC monograph final" or "OTC . (D) Additional warnings. The persons conducting tests shall permit the officer or employee to inspect and copy the records, to make such inventories of stock as the officer or employee deems necessary, and otherwise to check the correctness of the inventories. Please do not provide confidential Prescription hearing aid software that is not distributed with the hearing aid or amplification platform shall meet all of the following labeling requirements. ", An official website of the United States government, Recalls, Market Withdrawals and Safety Alerts, In Vitro Diagnostic Device Labeling Requirements, Labeling Requirements for Radiation Emitting Devices and Products, Quality System Regulation Labeling Requirements, Device Advice: Comprehensive Regulatory Assistance, Investigational Device Labeling Requirements, Labeling - Regulatory Requirements for Medical Devices (FDA 89-4203) (PDF - 3MB), Device Labeling Guidance #G91-1 (Blue Book Memo), Guidance on Medical Device Patient Labeling - Final Guidance for Industry and FDA Staff (PDF - 333KB), Section 206 of the Medical Device User Fee and Modernization Act (MDUFMA) (New section 502(f) of the Federal Food, Drug, and Cosmetic Act) Electronic Labeling for Prescription Devices Intended for Use in Health Care Facilities - #G03-1, November 2004 Medical Devices Technical Corrections Act (MDTCA) Expanded Authority for Electronic Labeling (PDF - 268KB), User Labeling for Devices that Contain Natural Rubber (21 CFR 801.437); Small Entity Compliance Guide - Guidance for Industry (PDF - 41KB), 'all labels and other written, printed, or graphic matter. A preweighed (to the nearest 0.01 gram) tampon is placed within the condom membrane so that the center of gravity of the tampon is at the center of the chamber. (h) All lenses must be impact-resistant except when the physician or optometrist finds that impact-resistant lenses will not fulfill the visual requirements for a particular patient. (f) Devices that have packaging containing natural rubber latex that contacts humans, as described in paragraph (b) of this section, shall bear the following statement in bold print on the device labeling: Caution: The Packaging of This Product Contains Natural Rubber Latex Which May Cause Allergic Reactions.. Variations from stated quantity of contents shall not be unreasonably large. (b) Such statement of identity shall be in terms of the common name of the device followed by an accurate statement of the principal intended action(s) of the device. However, a hearing aid shall not be used merely because a prospective user wore it as part of a bona fide hearing aid evaluation to determine whether to select that particular hearing aid for that prospective user. It shall be placed on the principal display panel within the bottom 30 percent of the area of the label panel in lines generally parallel to the base on which the package rests as it is designed to be displayed: Provided, That: (1) On packages having a principal display panel of 5 square inches or less the requirement for placement within the bottom 30 percent of the area of the label panel shall not apply when the declaration of net quantity of contents meets the other requirements of this part; and. user convenience only and is not intended to alter agency intent Title 21 was last amended 6/22/2023. [1] A significant FDA role in the regulation of these medications is supporting sponsors in their efforts to ensure adequate drug product labeling. A hearing aid is used if a user has worn it for any period of time. (ii) The use of symbols in device labeling which do not meet the requirements of paragraph (c)(1)(i) of this section renders a device misbranded under section 502(c) of the act. (3) Is explained in a paper or electronic symbols glossary that is included in the labeling for the device and the labeling on or within the package containing the device bears a prominent and conspicuous statement identifying the location of the symbols glossary that is written in English or, in the case of articles distributed solely in Puerto Rico or in a Territory where the predominant language is one other than English, the predominant language may be used; (E) A symbol not accompanied by adjacent explanatory text that: (1) Is established in a standard developed by a standards development organization (SDO); (2) Is not contained in a standard that is recognized by FDA under its authority in section 514(c) of the act or is contained in a standard that is recognized by FDA but is not used according to the specifications for use of the symbol set forth in FDA's section 514(c) recognition; (3) Is determined by the manufacturer to be likely to be read and understood by the ordinary individual under customary conditions of purchase and use in compliance with section 502(c) of the act; (4) Is used according to the specifications for use of the symbol set forth in the SDO-developed standard; and. A sticker under and visible through the outer wrapper will suffice to declare such fact. Accordingly, the labeling should contain substantially the following information: (1) For denture repair kits: Special training and tools are needed to repair dentures to fit properly. (1) The name, mailing address, email address, and phone number of the labeler who is currently using the labeler code; (2) The owner/operator account identification used by the labeler to submit registration and listing information using FDA's Unified Registration and Listing System (FURLS). (1) To protect the public more adequately from potential eye injury, eyeglasses and sunglasses must be fitted with impact-resistant lenses, except in those cases where the physician or optometrist finds that such lenses will not fulfill the visual requirements of the particular patient, directs in writing the use of other lenses, and gives written notification thereof to the patient. Rebuilt hearing aid. According to an appellate court decision: "Most, if not all advertising, is labeling. (d) FDA may initiate and grant an exception or alternative if we determine that the exception or alternative is in the best interest of the public health.